Canadian Nuclear Laboratories and Jubilant Radiopharma to collaborate on the development of novel alpha radiopharmaceuticals
First project funded through CNL’s Canadian Nuclear Research Initiative-Health program will advance research to develop new cancer treatments using Actinium-225 Chalk...